254 related articles for article (PubMed ID: 18359089)
21. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.
Aparna SB; Reddy VC; Gokhale S; Moorthy KV
Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):564-70. PubMed ID: 19243801
[TBL] [Abstract][Full Text] [Related]
22. The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality.
Wittenhagen P; Kronborg G; Weis N; Nielsen H; Obel N; Pedersen SS; Eugen-Olsen J
Clin Microbiol Infect; 2004 May; 10(5):409-15. PubMed ID: 15113317
[TBL] [Abstract][Full Text] [Related]
23. Association of serum levels of iron, copper, and zinc, and inflammatory markers with bacteriological sputum conversion during tuberculosis treatment.
Moraes ML; Ramalho DM; Delogo KN; Miranda PF; Mesquita ED; de Melo Guedes de Oliveira HM; Netto AR; Dos Anjos MJ; Kritski AL; de Oliveira MM
Biol Trace Elem Res; 2014 Aug; 160(2):176-84. PubMed ID: 24958018
[TBL] [Abstract][Full Text] [Related]
24. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
Sar B; Keo C; Leng C; Saman M; Min DC; Chan S; Monchy D; Sarthou JL
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041
[TBL] [Abstract][Full Text] [Related]
25. [Estimation of serum C-reactive protein values in patients with pulmonary tuberculosis].
Kaminskaia GO; Abdullaev RIu; Komissarova OG
Probl Tuberk Bolezn Legk; 2008; (10):50-4. PubMed ID: 19069195
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of soluble haemoglobin scavenger receptor CD163 serum levels for survival in verified tuberculosis patients.
Knudsen TB; Gustafson P; Kronborg G; Kristiansen TB; Moestrup SK; Nielsen JO; Gomes V; Aaby P; Lisse I; Møller HJ; Eugen-Olsen J
Clin Microbiol Infect; 2005 Sep; 11(9):730-5. PubMed ID: 16104988
[TBL] [Abstract][Full Text] [Related]
27. Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders.
Veenstra H; Baumann R; Carroll NM; Lukey PT; Kidd M; Beyers N; Bolliger CT; van Helden PD; Walzl G
Clin Exp Immunol; 2006 Aug; 145(2):252-60. PubMed ID: 16879244
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of care for elderly pulmonary tuberculosis patients].
Sasaki Y; Yamagishi F; Yagi T; Hashimoto T; Bekku R; Kawasaki T; Shinozaki A
Kekkaku; 2007 Oct; 82(10):733-9. PubMed ID: 18018597
[TBL] [Abstract][Full Text] [Related]
30. [The role of serum neopterin level in the evaluation of activation and response to treatment in the patients with pulmonary tuberculosis].
Güler M; Hüddam D; Unsal E; Ciftçi B; Bukan N; Erdoğan Y; Capan N
Tuberk Toraks; 2006; 54(4):330-5. PubMed ID: 17203418
[TBL] [Abstract][Full Text] [Related]
31. Quantitative bacillary response to treatment in Mycobacterium tuberculosis infected and M. africanum infected adults with pulmonary tuberculosis.
Joloba ML; Johnson JL; Namale A; Morrissey A; Assegghai AE; Rüsch-Gerdes S; Mugerwa RD; Ellner JJ; Eisenach KD
Int J Tuberc Lung Dis; 2001 Jun; 5(6):579-82. PubMed ID: 11409588
[TBL] [Abstract][Full Text] [Related]
32. [The results of the use of riboxin in the combined treatment of patients with pulmonary tuberculosis].
Aleksandrova AE; Borisova LE; Vasil'ev AV
Probl Tuberk; 1989; (9):28-33. PubMed ID: 2511573
[TBL] [Abstract][Full Text] [Related]
33. [Case of pulmonary tuberculosis with miliary granules, mediastinal lymph node enlargement and elevation of soluble interleukin-2 receptor].
Tabata H; Mochizuki Y; Nakahara Y; Kawamura T; Sasaki S; Tsukamoto H
Kekkaku; 2009 Jun; 84(6):485-9. PubMed ID: 19588853
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of interleukin-4 (IL-4) and IL-4 delta 2 mRNA, but not transforming growth factor beta (TGF-beta), TGF-beta RII, Foxp3, gamma interferon, T-bet, or GATA-3 mRNA, in patients with fast and slow responses to antituberculosis treatment.
Djoba Siawaya JF; Bapela NB; Ronacher K; Beyers N; van Helden P; Walzl G
Clin Vaccine Immunol; 2008 Aug; 15(8):1165-70. PubMed ID: 18579694
[TBL] [Abstract][Full Text] [Related]
35. Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome.
Ostrowski SR; Ullum H; Goka BQ; Høyer-Hansen G; Obeng-Adjei G; Pedersen BK; Akanmori BD; Kurtzhals JA
J Infect Dis; 2005 Apr; 191(8):1331-41. PubMed ID: 15776381
[TBL] [Abstract][Full Text] [Related]
36. Whole blood bactericidal activity during treatment of pulmonary tuberculosis.
Wallis RS; Vinhas SA; Johnson JL; Ribeiro FC; Palaci M; Peres RL; Sá RT; Dietze R; Chiunda A; Eisenach K; Ellner JJ
J Infect Dis; 2003 Jan; 187(2):270-8. PubMed ID: 12552451
[TBL] [Abstract][Full Text] [Related]
37. Early stationary phase culture supernatant accelerates growth of sputum cultures collected after initiation of anti-tuberculosis treatment.
Kolwijck E; Friedrich SO; Karinja MN; van Ingen J; Warren RM; Diacon AH
Clin Microbiol Infect; 2014 Jul; 20(7):O418-20. PubMed ID: 24188165
[TBL] [Abstract][Full Text] [Related]
38. Circulating levels of high-sensitivity C-reactive protein and soluble markers of vascular endothelial cell activation in growth hormone-deficient adolescents.
Lanes R; Marcano H; Villaroel O; Gunczler P; Morillo E; Paoli M; Perez M; Maulino N; Palacios A
Horm Res; 2008; 70(4):230-5. PubMed ID: 18772596
[TBL] [Abstract][Full Text] [Related]
39. Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.
Jayakumar A; Vittinghoff E; Segal MR; MacKenzie WR; Johnson JL; Gitta P; Saukkonen J; Anderson J; Weiner M; Engle M; Yoon C; Kato-Maeda M; Nahid P;
Tuberculosis (Edinb); 2015 Jul; 95(4):415-20. PubMed ID: 26022314
[TBL] [Abstract][Full Text] [Related]
40. [Study on pathogenicity of sputum from cavity of sputum negative patients with pulmonary tuberculosis after short course chemotherapy].
Feng H; Du B; Dong Z
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Sep; 23(9):559-62. PubMed ID: 11778533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
